Tasigna and Combivent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tasigna (nilotinib hydrochloride monohydrate) and Combivent (albuterol sulfate; ipratropium bromide). Common drug interactions include piloerection among females and food interaction among males.

The phase IV clinical study analyzes what interactions people have when they take Tasigna and Combivent. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Tasigna?

Tasigna has active ingredients of nilotinib hydrochloride monohydrate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 31,535 Tasigna users. Check the latest studies of Tasigna.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in asthma. eHealthMe is studying from 35,341 Combivent users. Check the latest studies of Combivent.

On Jul, 18, 2026

35 people who take Tasigna and Combivent together, and have interactions are studied.

Tasigna and Combivent drug interactions.

What are the common drug interactions of Tasigna and Combivent, by gender? *:

female:

Piloerection (goose bumps)
Pruritus (severe itching of the skin)
Rash
Splenomegaly (enlargement of spleen)
Electrocardiogram qt prolonged
Abdominal distension
Abdominal pain
Abdominal pain upper
Abnormal loss of weight
Alanine aminotransferase increased

male:

Food interaction
Therapeutic response decreased (less preventive response)
Dizziness
Fatigue (feeling of tiredness)
Femoral artery occlusion (obstruction in artery of femur)
Headache (pain in head)
Hypoxia (low oxygen in tissues)
Intermittent claudication
Lipase increased
Malaise (a feeling of general discomfort or uneasiness)

What are the common drug interactions of Tasigna and Combivent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Food interaction
Therapeutic response decreased (less preventive response)

40-49:

Abdominal distension
Anxiety
Arthralgia (joint pain)
Bone pain
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Dizziness
Drug ineffective
Dysphonia (speech disorder attributable to a disorder of phonation)
Ear discomfort

50-59:

Ocular hyperaemia (an abnormally large amount of blood in eye)
Dizziness
Asthenia (weakness)
Extrasystoles
Piloerection (goose bumps)
Pruritus (severe itching of the skin)
Rash
Electrocardiogram qt prolonged
Diarrhoea
Fatigue (feeling of tiredness)

60+:

Pneumonia
Abnormal faeces (abnormal stool)
Blood urea increased
Bone callus excessive (excessive bony deposit formed between and around the broken ends of bone fractures)
Contusion (a type of hematoma of tissue in which capillaries)
Femur fracture
Flatulence (flatus expelled through the anus)
Haemoglobin decreased
Injury
Joint range of motion decreased (disease of joint movement)

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 24 people, 68.57%
High Blood Pressure: 13 people, 37.14%
Type 2 Diabetes: 11 people, 31.43%
Productive Cough: 11 people, 31.43%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 11 people, 31.43%
Insomnia (sleeplessness): 11 people, 31.43%
Arrhythmias (irregular heartbeat): 11 people, 31.43%
Cough: 8 people, 22.86%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 5 people, 14.29%
Back Pain: 5 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Tasigna and Combivent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously